Search

Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer.

… Saturday, September 26, 2015 Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer. In the studies,

Catch up with some of the patients we got to know in 2017.

… Thursday, December 28, 2017 Everyone touched by cancer has a story to tell. We reconnected with just a few of the inspiring people we met in 2017 to see how they’re doing today. Tim Waples It’s been five years since Tim, a special education teacher from Emerson, New Jersey, completed treatment for non-Hodgkin

At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure.

… Monday, November 11, 2019 At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure. Gallbladder

Read our suggestions for getting through the holiday season while facing cancer.

… Tuesday, November 7, 2017 Summary The holiday season brings unique challenges for people with cancer. Social worker Jackie LaGrassa has tips for how to manage. The holidays are stressful enough. Having cancer can make for an especially trying season. “There are expectations that you’re going to show

Cancer knows no borders or languages. For most people newly diagnosed with cancer, it’s hard enough trying to understand their diagnosis, treatment options, and the life changes that lie ahead without also having to contend with a language barrier. The challenges are even more daunting for people facing an advanced, life-threatening disease.

… Wednesday, April 13, 2022 Cancer knows no borders or languages. For most people newly diagnosed with cancer, it’s hard enough trying to understand their diagnosis, treatment options, and the life changes that lie ahead without also having to contend with a language barrier. The challenges are even more

El cáncer no conoce fronteras ni idiomas. Para la mayoría de las personas recién diagnosticadas con cáncer, ya es bastante difícil tratar de comprender su diagnóstico, las opciones de tratamiento y los cambios de vida que les esperan sin tener que lidiar con una barrera del idioma. Los desafíos son aún más desalentadores para las personas que enfrentan una enfermedad avanzada y potencialmente mortal.

… Wednesday, April 13, 2022 El cáncer no conoce fronteras ni idiomas. Para la mayoría de las personas recién diagnosticadas con cáncer, ya es bastante difícil tratar de comprender su diagnóstico, las opciones de tratamiento y los cambios de vida que les esperan sin tener que lidiar con una barrera del

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Friday, December 17, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Craig B. Thompson Named to AMNY Metro and PoliticsNY’s Power Players in Health Care List Craig B. Thompson Craig B. Thompson, MD , President and CEO, has been named to the first AMNY

Our students’ research is recognized with the Geoffrey Beene Graduate Student Fellowships, the Catell Fellowship, the Olayan Fellowship, and the Palestin Fellowship.

… Saturday, October 1, 2011 Geoffrey Beene Graduate Student Fellowships Announced Three second-year students — Robert Bowman, Jenny Karo, and Gregory Mazo — received Geoffrey Beene Graduate Student Fellowships . Recipients are selected at the end of their first year of study based on academic excellence

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) surveillance. However, if patients with a high risk of brain metastasis after surgical resection can be identified, surveillance and prophylactic treatment with CNS-directed therapies may improve outcomes.

… Monday, March 24, 2025 Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) surveillance. However, if patients with a high risk of brain metastasis after

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to selpercatinib (Retevmo™) for lung and thyroid cancers with RET (REarranged during Transfection) gene mutations or fusions.

… Tuesday, May 26, 2020 Update: On September 21, 2022, the U.S. Food and Drug Administration (FDA) expanded the approval of selpercatinib (Retevmo TM ) beyond treating lung and thyroid cancers. The drug is now approved for adults with any locally advanced or metastatic solid tumor carrying a RET gene fusion